Active Ingredient: MICAFUNGIN SODIUM
Proprietary Name: MICAFUNGIN SODIUM
Dosage Form; Route of Administration: INJECTABLE; INTRAVENOUS
Strength: EQ 100MG BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A211713
Product Number: 002
Approval Date: Jun 2, 2021
Applicant Holder Full Name: XELLIA PHARMACEUTICALS APS
Marketing Status:
Prescription
Patent and Exclusivity Information